Molecular interactions of FGF23 and PTH in phosphate regulation

Kidney International

Volumn 86, Issue 6, 2014, Pages 1072-1074

  Lanske, Beate ^a   Razzaque, Mohammed S ^b  

^a HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

^b FORSYTH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; FIBROBLAST GROWTH FACTOR 23; NUCLEAR RECEPTOR RELATED FACTOR 1; PARATHYROID HORMONE; PHOSPHATE; FIBROBLAST GROWTH FACTOR; MESSENGER RNA;

BONE CELL; BONE MASS; CELLULAR DISTRIBUTION; FEEDBACK SYSTEM; HORMONE PROTEIN COMPLEX; HYPERPHOSPHATEMIA; HYPOPHOSPHATEMIA; MOUSE MODEL; NONHUMAN; OSTEOPOROSIS; PARATHYROID HORMONE RELEASE; PHOSPHATE BLOOD LEVEL; PHOSPHATE METABOLISM; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; VITAMIN METABOLISM; ANIMAL; DRUG EFFECTS; GENETIC TRANSCRIPTION; GENETICS; MALE; METABOLISM;

ANIMALS; FIBROBLAST GROWTH FACTORS; MALE; NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 2; PARATHYROID HORMONE; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 84926021852     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2014.316     Document Type: Note

References (12)

1. Razzaque MS. The FGF23-Klotho axis: endocrine regulation of phosphate homeostasis. Nat Rev Endocrinol 2009; 5: 611-619.
2. Hu MC, Shi M, Zhang J et al. Klotho: A novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule. FASEB J 2010; 24: 3438-3450.
3. Goetz R, Nakada Y, Hu MC et al. Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation. Proc Natl Acad Sci USA 2010; 107: 407-412.
4. Goetz R, Ohnishi M, Kir S et al. Conversion of a paracrine fibroblast growth factor into an endocrine fibroblast growth factor. J Biol Chem 2012; 287: 29134-29146.
5. Tagliabracci VS, Engel JL, Wiley SE et al. Dynamic regulation of FGF23 by Fam20C phosphorylation, GalNAc-T3 glycosylation, and furin proteolysis. Proc Natl Acad Sci USA 2014; 111: 5520-5525.
6. Nakatani T, Ohnishi M, Razzaque MS. Inactivation of klotho function induces hyperphosphatemia even in presence of high serum fibroblast growth factor 23 levels in a genetically engineered hypophosphatemic (Hyp) mouse model. FASEB J 2009; 23: 3702-3711.
7. Ichikawa S, Imel EA, Kreiter ML et al. A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis. J Clin Invest 2007; 117: 2684-2691.
8. Yuan Q, Sitara D, Sato T et al. PTH ablation ameliorates the anomalies of Fgf23-deficient mice by suppressing the elevated vitamin D and calcium levels. Endocrinology 2011; 152: 4053-4061.
9. Kawata T, Imanishi Y, Kobayashi K et al. Parathyroid hormone regulates fibroblast growth factor-23 in a mouse model of primary hyperparathyroidism. J Am Soc Nephrol 2007; 18: 2683-2688.
10. Krajisnik T, Bjorklund P, Marsell R et al. Fibroblast growth factor-23 regulates parathyroid hormone and 1alphahydroxylase expression in cultured bovine parathyroid cells. J Endocrinol 2007; 195: 125-131.
11. Uchihashi K, Nakatani T, Goetz R et al. FGF23-induced hypophosphatemia persists in Hyp mice deficient in the WNT coreceptor Lrp6. Contrib Nephrol 2013; 180: 124-137.
12. Meir T, Durlacher K, Amir G et al. PTH activates the orphan nuclear receptor Nurr1 to induce FGF23 transcription. Kidney Int 2014; 86: 1106-1115.